MedTrace Logo

Adult Stem Cell Therapy in Liver Insufficiency

NCT00147043 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2019-10-03

Study results available
· View outcomes & findings →

Summary

In order to determine the clinical application potential of adult stem cells we propose to investigate the safety and toxicity of infusing adult stem cells in the hepatic artery or portal vein of five patients with chronic liver insufficiency and to identify any clinical benefit if such occurs.

Objectives:

1. To assess safety and treatment related toxicities
2. To determine clinical benefit or deterioration by monitoring changes in liver function

Conditions

Interventions

PROCEDURE

Leukapheresis

PROCEDURE

Infusion of stem cells via image guided scan

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Nagy Habib, ChM FRCS · Imperial College London

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2005-06-30
Completion
2005-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00147043 on ClinicalTrials.gov